Related Experiment Video

Updated: May 31, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Association between peak serum bilirubin and neurodevelopmental outcomes in term babies with hyperbilirubinemia

Thirunavukkarasu Arun Babu1, Vishnu Bhat B, Noyal Mariya Joseph

  • 1Department of Pediatrics, Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Puducherry 605 006, India.

Indian Journal of Pediatrics
|June 28, 2011
PubMed

Insights

High peak serum bilirubin (PSB) levels in newborns with jaundice, specifically ≥ 22 mg/dl, are linked to abnormal neurodevelopmental outcomes at 6 months. Rh incompatibility and early jaundice onset are also significant risk factors.

Area of Science:

  • Neonatalogy
  • Pediatric Neurology
  • Public Health

Background:

  • Neonatal hyperbilirubinemia, characterized by elevated bilirubin levels, is common in newborns.
  • Severe hyperbilirubinemia poses a risk for neurodevelopmental impairment.
  • Understanding predictors of adverse outcomes is crucial for timely intervention.

Purpose of the Study:

  • To investigate the association between peak serum bilirubin (PSB) levels and neurodevelopmental outcomes at 6 months in term infants.
  • To identify specific risk factors for abnormal neurodevelopment in term infants with neonatal jaundice.

Main Methods:

  • Prospective cohort study of 66 term infants with neonatal jaundice (PSB > 15 mg/dl).
  • Exclusion of infants with conditions affecting neurodevelopment (e.g., prematurity, convulsions, asphyxia).
  • Neurodevelopmental assessment at 6 months of age.

Main Results:

  • Abnormal neurodevelopmental quotient increased with higher PSB levels.
  • PSB ≥ 22 mg/dl, Rh incompatibility, and jaundice within 2 days of life were significant risk factors for abnormal development.
  • Multivariate analysis confirmed these three factors as independent predictors.

Conclusions:

  • Peak serum bilirubin levels ≥ 22 mg/dl are an independent predictor of abnormal neurodevelopment in term infants with jaundice.
  • Rh incompatibility and early onset of jaundice (within 2 days of life) are also independent predictors of adverse neurodevelopmental outcomes.
Abstract

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates05:58

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

Published on: September 6, 2017

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...